New antibody aims to calm heart artery inflammation
NCT ID NCT06572267
Summary
This study is testing whether a medication called meplazumab can help control coronary artery disease by reducing inflammation and plaque buildup in heart arteries. Eighteen patients with stable coronary artery disease will receive either the antibody treatment or a placebo to see if it safely improves their condition. Researchers will measure changes in artery plaque and inflammation markers over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ling Tao
RECRUITINGXi'an, Shannxi, 710032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.